Episodes (Page 32)
✨
CAR-T therapies and malignancies discussed.
✨
FDA acknowledges malignancy reports with CAR-T immunotherapies.
✨
Sara Barrington discusses Verici DX's RNA-based diagnostic product.
Sara Barrington
✨
Bayer's Phase III failure and US group seeking Japan changes.
✨
Current trends in global epidemiology and data applications.
Asma Ali
Lucia Rodriguez-Garcia
Maya Trivedy
Ridwaan Ibrahim
✨
Jeremy Levin accepts Scrip's Lifetime Achievement Award.
✨
Current landscape and future direction of digital therapeutics.
Andy Molnar
Joel Morse
Owen McCarthy
✨
FDA approval of Chinese PD-1 drugs and Sanofi BioMap AI deal.
✨
Digital twins and biowearables from Abbott and Twin Health discussed.
Digital Twins
✨
AstraZeneca CEO discusses obesity; biotech faces continued volatility.
✨
Reflecting on Janet Woodcock's legacy as US FDA Principal Deputy Commissioner.